IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Evotec Sells Drug Development Arm

11:07 AM MDT | September 18, 2007 |

Alex Scott

Drug discovery firm Evotec (Hamburg, Germany) says it has sold its chemical development business to drug development services group Aptuit (Greenwich, CT) for $64 million in cash. Evotec’s chemical development business is comprised of activities in process research and development, custom preparation, analytical development, pilot plant manufacturing and formulation. The business has a total of about 210 people based in Oxford and Glasgow, U.K. and generated sales in 2006 of EUR €26.8 million ($37.2 million). "This acquisition continues Aptuit's...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa